Cytogen Corporation

Cytogen is a biopharmaceutical company focused on the development and commercialization of drug products for cancer patients. Cytogen sells QUADRAMET, PROSTASCINT, CAPHOSOL, and SOLTAMOX. It has also developed CYT-500, a third-generation radiolabeled antibody for the treatment of prostate cancer. Cytogen was acquired by EUSA Pharma in May 2008. Cytogen was founded by Thomas J. McKearn in 1980 and is headquartered in Princeton, New Jersey.